Does hypoxia really control tumor growth? [1]

Cellular Oncology

Volumn 28, Issue 5-6, 2006, Pages 327-329

  López Lázaro, Miguel ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; OXYGEN; SUPEROXIDE;

BIOSYNTHESIS; CELL PROLIFERATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOLYSIS; HUMAN; HYPOXIA; LETTER; OXYGEN BLOOD LEVEL; OXYGEN CONCENTRATION; OXYGEN SUPPLY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR GROWTH;

CELL HYPOXIA; CELL PROLIFERATION; GENES, NEOPLASM; GLYCOLYSIS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; OXYGEN; REACTIVE OXYGEN SPECIES;

EID: 33845609726     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (26)

1. B. Alberts, A. Johnson, J. Lewis, M. Raff, K. Roberts and P. Walter, Molecular biology of the cell, 4th edition, ed., Garland Publishing, New York, 2002.
2. R.S. Arnold, J. Shi, E. Murad, A.M. Whalen, C.Q. Sun, R. Polavarapu, et al., Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1, Proc. Natl. Acad. Sci. U.S.A. 98 (2001), 5550-5555.
3. T. Bui and C.B. Thompson, Cancer's sweet tooth, Cancer Cell 9 (2006), 419-420.
4. R.H. Burdon, Superoxide and hydrogen peroxide in relation to mammalian cell proliferation, Free Radic. Biol. Med. 18 (1995), 775-794.
5. J.M. Cuezva, G. Chen, A.M. Alonso, A. Isidoro, D.E. Misek, S.M. Hanash, et al., The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis, Carcinogenesis 25 (2004), 1157-1163.
6. J.M. Cuezva, M. Krajewska, M.L. de Heredia, S. Krajewski, G. Santamaria, H. Kim, et al., The bioenergetic signature of cancer: a marker of tumor progression, Cancer Res. 62 (2002), 6674-6681.
7. V.R. Fantin, J. St Pierre and P. Leder, Attenuation of LDHA expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance, Cancer Cell 9 (2006), 425-434.
8. K. Garber, Energy deregulation: licensing tumors to grow, Science 312 (2006), 1158-1159.
9. R.A. Gatenby and R.J. Gillies, Why do cancers have high aerobic glycolysis?, Nat. Rev. Cancer 4 (2004), 891-899.
10. J.J. Haddad and S.C. Land, A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1 alpha, FEBS Lett. 505 (2001), 269-274.
11. A.L. Harris, Hypoxia - a key regulatory factor in tumour growth, Nat. Rev. Cancer 2 (2002), 38-47.
12. A. Isidoro, E. Casado, A. Redondo, P. Acebo, E. Espinosa, A.M. Alonso, et al., Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis, Carcinogenesis 26 (2005), 2095-2104.
13. A. Isidoro, M. Martinez, P.L. Fernandez, A.D. Ortega, G. Santamaria, M. Chamorro, et al., Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer, Biochem. J. 378 (2004), 17-20.
14. M. Lopez-Lazaro, HIF-1: Hypoxia-inducible Factor or Dysoxia-inducible Factor?, FASEB J. 20 (2006), 828-832.
15. H. Lu, C. Dalgard, A. Mohyeldin, T. McFate, A.S. Tait and A. Verma, Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1, J. Biol. Chem. 280 (2005), 41928-41939.
16. H. Lu, R.A. Forbes and A. Verma, Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis, J. Biol. Chem. 277 (2002), 23111-23115.
17. J. Pouyssegur, F. Dayan and N.M. Mazure, Hypoxia signalling in cancer and approaches to enforce tumour regression, Nature 441 (2006), 437-443.
18. A. Ramanathan, C. Wang and S.L. Schreiber, Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements, Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 5992-5997.
19. G.L. Semenza, Development of novel therapeutic strategies that target HIF-1, Expert Opin. Ther. Targets 10 (2006), 267-280.
20. G.L. Semenza, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer 3 (2003), 721-732.
21. T.P. Szatrowski and C.F. Nathan, Production of large amounts of hydrogen peroxide by human tumor cells, Cancer Res. 51 (1991), 794-798.
22. B. Vogelstein and K.W. Kinzler, Cancer genes and the pathways they control, Nat. Med. 10 (2004), 789-799.
23. R.H. Xu, H. Pelicano, Y. Zhou, J.S. Carew, L. Feng, K.N. Bhalla, et al., Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia, Cancer Res. 65 (2005), 613-621.
24. J.Q. Yang, G.R. Buettner, F.E. Domann, Q. Li, J.F. Engelhardt, C.D. Weydert, et al., v-Ha-ras mitogenic signaling through superoxide and derived reactive oxygen species, Mol. Carcinog. 33 (2002), 206-218.
25. H. Zhong, A.M. De Marzo, E. Laughner, M. Lim, D.A. Hilton, D. Zagzag, et al., Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases, Cancer Res. 59 (1999), 5830-5835.
26. H. Zhong, N. Mabjeesh, M. Willard and J. Simons, Nuclear expression of hypoxia-inducible factor 1 alpha protein is heterogeneous in human malignant cells under normoxic conditions, Cancer Lett. 181 (2002), 233-238.